To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
A team from the SCBM, in collaboration with the SPI, the IC2MP and the University Hospital of Poitiers, has developed a bioorthogonal chemistry strategy that allows, in vivo, the controlled release of active ingredients contained in micelles-targeting cancerous tumors. These results pave the way for new strategies for targeted drug delivery.
Very high-resolution MRI will provide particularly detailed images of the brain. However, the acquisition times of MRI data strongly increase with resolution. To solve this problem, the mathematicians at NeuroSpin have developed an algorithm that allows to gain a factor of 20 !
A collaboration between SIMOPRO, Sanofi R & D, Smartox Laboratories and the Thorax Institute, has isolated a toxin with antinociceptive properties from a high-throughput electrophysiological screening of a collection of more than 100 venoms. Cyriotoxin-1a has been identified, sequenced, chemically synthesized and functionally characterized - from cell to organism in vivo.
Facilitating the deuterium and tritium labeling of molecules containing nucleic bases such as many compounds of pharmacological interest? This is what researchers from SCBM in partnership with teams from SPI and Toulouse managed to achieve.
Glioblastoma is a very aggressive cancer of the central nervous system, mainly because of its ability to infiltrate the surrounding areas. A collaboration led by a team of SHFJ and involving NeuroSpin demonstrates the interest of two imaging techniques for the early detection of tumor infiltration.
A team of SB2SM (I2BC@Saclay), in collaboration with the universities of South-Paris and Rennes1, has developed a new, particularly effective catalyst for the reduction of carbon dioxide (CO2), directly inspired by nature. Results are published in Angewandte Chemie.
An international collaboration led by a team from the ICM (Brain and Spine Institute) shows that it is possible to assess states of consciousness through an imaging process developed at NeuroSpin. This new tool could help to better diagnose alterations of consciousness. The results were published in Science Advances.
A team from SHFJ proposes a predictive model that corrects the "acquisition center" effect thanks to an unprecedented harmonization method in medical imaging.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.